Ardelyx, Inc. (ARDX) stock
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.06−0.06 (-1.92%)
Close on Nov 19, 2026Market cap $762.51MP/E –Yield –
Ardelyx free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Ardelyx's free cash flow for the twelve months ending Jun 30, 2026 was -$17.92M. For fiscal 2025 it was -$43.98M. The highest annual figure on record is $21.85M in fiscal 2012.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$43.98M | – |
| FY2024 | Dec 31, 2024 | -$45.82M | – |
| FY2023 | Dec 31, 2023 | -$90.06M | – |
| FY2022 | Dec 31, 2022 | -$70.10M | – |
| FY2021 | Dec 31, 2021 | -$154.42M | – |
| FY2020 | Dec 31, 2020 | -$81.76M | – |
| FY2019 | Dec 31, 2019 | -$76.81M | – |
| FY2018 | Dec 31, 2018 | -$70.59M | – |
| FY2017 | Dec 31, 2017 | -$67.55M | – |
| FY2016 | Dec 31, 2016 | -$97.40M | – |
| FY2015 | Dec 31, 2015 | -$75.29M | -752.4% |
| FY2014 | Dec 31, 2014 | $11.54M | +652.8% |
| FY2013 | Dec 31, 2013 | $1.53M | -93.0% |
| FY2012 | Dec 31, 2012 | $21.85M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.41M | – |
| Q1 FY2026 | Mar 31, 2026 | -$32.31M | – |
| Q4 FY2025 | Dec 31, 2025 | $20.59M | +123.4% |
| Q3 FY2025 | Sep 30, 2025 | $209.00K | -42.6% |
| Q2 FY2025 | Jun 30, 2025 | -$25.99M | – |
| Q1 FY2025 | Mar 31, 2025 | -$38.78M | – |
| Q4 FY2024 | Dec 31, 2024 | $9.22M | – |
| Q3 FY2024 | Sep 30, 2024 | $364.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$19.53M | – |
| Q1 FY2024 | Mar 31, 2024 | -$35.87M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.76M | -161.6% |
| Q3 FY2023 | Sep 30, 2023 | -$21.66M | – |
| Q2 FY2023 | Jun 30, 2023 | -$14.83M | – |
| Q1 FY2023 | Mar 31, 2023 | -$44.81M | – |
| Q4 FY2022 | Dec 31, 2022 | $14.23M | – |
| Q3 FY2022 | Sep 30, 2022 | -$25.43M | – |
| Q2 FY2022 | Jun 30, 2022 | -$31.28M | – |
| Q1 FY2022 | Mar 31, 2022 | -$27.62M | – |
| Q4 FY2021 | Dec 31, 2021 | -$39.37M | – |
| Q3 FY2021 | Sep 30, 2021 | -$35.03M | – |
| Q2 FY2021 | Jun 30, 2021 | -$35.02M | – |
| Q1 FY2021 | Mar 31, 2021 | -$45.00M | – |
| Q4 FY2020 | Dec 31, 2020 | -$17.84M | – |
| Q3 FY2020 | Sep 30, 2020 | -$19.93M | – |
| Q2 FY2020 | Jun 30, 2020 | -$19.02M | – |
| Q1 FY2020 | Mar 31, 2020 | -$24.97M | – |
| Q4 FY2019 | Dec 31, 2019 | -$11.14M | – |
| Q3 FY2019 | Sep 30, 2019 | -$20.73M | – |
| Q2 FY2019 | Jun 30, 2019 | -$27.87M | – |
| Q1 FY2019 | Mar 31, 2019 | -$17.08M | – |
| Q4 FY2018 | Dec 31, 2018 | -$18.72M | -500.9% |
| Q3 FY2018 | Sep 30, 2018 | -$26.99M | – |
| Q2 FY2018 | Jun 30, 2018 | -$18.02M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.86M | – |
| Q4 FY2017 | Dec 31, 2017 | $4.67M | – |
| Q3 FY2017 | Sep 30, 2017 | -$19.66M | – |
| Q2 FY2017 | Jun 30, 2017 | -$24.68M | – |
| Q1 FY2017 | Mar 31, 2017 | -$27.88M | – |
| Q4 FY2016 | Dec 31, 2016 | -$29.51M | – |
| Q3 FY2016 | Sep 30, 2016 | -$26.25M | – |
See a number that looks wrong?